OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
February 02, 2011
Will 2011 be a more promising year for new molecular entities? A review of Big Pharma's late-stage pipeline shows what might lie ahead.
As biologic-drug patents move toward expiration in the US, Indian firms with experience in the follow-on biologics arena are eager to partner with global manufacturers and secure their place in the growing biosimilars market.
Legislation has hampered cross-border drug importation and limited choice.
Q&A with Magnetrol International's Dan Klees
Food-safety, transparency, and counterfeit-drug growth will tax agency resources.
More crucial biomanufacturing operations are expected to be outsourced.
Anticounterfeiting solutions for vials and syringes.
As the industry prepares for Informex, the trade show of custom and batch manufacturers in Charlotte, North Carolina, a roundup of key recent developments.
Innovations protect the quality of temperature-sensitive products.
February 01, 2011
The authors highlight the need for a technology-transfer process that is efficient, cost-effective, and repeatable, stressing the importance of process understanding. Read this and other preferred organization articles in this special issue.